## Clinical Analysis **Key Point:** This infant has **ABO hemolytic disease of the newborn (HDN)** with evidence of active hemolysis (elevated reticulocyte count, positive Coombs test, early-onset jaundice at 24 hours). Management requires aggressive phototherapy and close monitoring for exchange transfusion criteria. ### Diagnostic Features of ABO HDN | Feature | Finding in This Case | Significance | | --- | --- | --- | | **Maternal blood group** | O negative | O mothers have naturally occurring anti-A and anti-B IgG antibodies | | **Infant blood group** | A positive | Incompatible with maternal O blood group | | **Coombs test** | Positive (1+ IgG) | Confirms IgG-mediated hemolysis | | **Reticulocyte count** | 8% (elevated) | Indicates active hemolysis and bone marrow response | | **Onset of jaundice** | 24 hours (early) | Suggests hemolytic process rather than physiological jaundice | | **Hemoglobin** | 14 g/dL (normal) | Hemolysis may not yet cause significant anemia | | **Bilirubin at 24 h** | 12 mg/dL | Exceeds phototherapy threshold for 24-hour-old term infant (≈ 10 mg/dL) | **High-Yield:** ABO incompatibility is the most common cause of hemolytic disease in the newborn in developed countries (more common than Rh disease due to widespread Rh prophylaxis). Severity ranges from mild to severe; this infant shows signs of moderate disease. ### Phototherapy Threshold for 24-Hour-Old Term/Near-Term Infant According to the **AAP phototherapy nomogram** [cite:Bhutani VK, et al. 2009]: - **≥ 35 weeks gestation:** Phototherapy threshold at 24 hours ≈ 10 mg/dL (for term infants) - **This infant at 36 weeks:** Threshold ≈ 10–11 mg/dL - **Current bilirubin (12 mg/dL):** Exceeds threshold → **phototherapy indicated immediately** ### Why Phototherapy + Monitoring (Not Observation Alone, Not Immediate Exchange) 1. **Phototherapy is indicated now:** Bilirubin exceeds the 24-hour threshold; waiting 24 hours risks further rise and potential kernicterus. 2. **Exchange transfusion is not yet indicated:** Current bilirubin (12 mg/dL) is below the exchange transfusion threshold at 24 hours (typically 17–18 mg/dL for term infants). However, given the evidence of hemolysis (positive Coombs, elevated reticulocyte count), this infant is at **high risk of rapid bilirubin rise** and will need close monitoring. 3. **Close follow-up is essential:** Recheck bilirubin in 4–6 hours (not 24 hours, as in observation-only approach) because hemolytic disease can cause steep bilirubin rise. If bilirubin rises toward or exceeds 20 mg/dL, exchange transfusion should be considered. **Clinical Pearl:** In hemolytic disease, bilirubin can rise 0.2 mg/dL/hour or faster. Infants with positive Coombs test and elevated reticulocyte count require **intensive phototherapy** (double or triple phototherapy) and frequent monitoring (every 4–6 hours initially). ### Management Algorithm ```mermaid flowchart TD A["ABO HDN: Positive Coombs, Elevated Retic, Early Jaundice"]:::outcome A --> B{"Bilirubin exceeds phototherapy threshold?"}:::decision B -->|Yes| C["Start phototherapy immediately"]:::action C --> D{"Bilirubin rising rapidly or approaching exchange threshold?"}:::decision D -->|Yes| E["Consider exchange transfusion"]:::action D -->|No| F["Continue phototherapy, recheck q4-6h"]:::action B -->|No| G["Observe, recheck q4-6h"]:::action E --> H["Exchange transfusion if threshold met"]:::urgent ``` [cite:Bhutani VK, et al. Phototherapy to prevent severe neonatal hyperbilirubinemia in the newborn >= 35 weeks of gestation. Pediatrics. 2009;123(5):1352-1359.] 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.